Glucocorticoid_NN
receptors_NNS
in_IN
anorexia_NN
nervosa_NN
and_CC
Cushing_NN
's_POS
disease_NN
._.

BACKGROUND_NN
:_:
Patients_NNS
with_IN
anorexia_NN
nervosa_NN
do_VBP
not_RB
display_VB
cushingoid_JJ
features_NNS
in_IN
spite_NN
of_IN
elevated_JJ
cortisol_NN
plasma_NN
levels_NNS
._.

Whether_IN
a_DT
cortisol_NN
resistance_NN
or_CC
a_DT
reduced_VBN
availability_NN
of_IN
the_DT
metabolic_JJ
substrates_NNS
necessary_JJ
to_TO
develop_VB
the_DT
effect_NN
of_IN
glucocorticoids_NNS
is_VBZ
responsible_JJ
for_IN
this_DT
has_VBZ
not_RB
been_VBN
established_VBN
._.

METHODS_NNS
:_:
Twenty-two_CD
patients_NNS
with_IN
severe_JJ
restrictive_JJ
anorexia_NN
nervosa_NN
,_,
10_CD
patients_NNS
with_IN
active_JJ
Cushing_NN
's_POS
disease_NN
,_,
and_CC
24_CD
healthy_JJ
volunteers_NNS
without_IN
psychiatric_JJ
disorders_NNS
or_CC
mood_NN
alterations_NNS
were_VBD
investigated_VBN
._.

Glucocorticoid_NN
receptor_NN
characteristics_NNS
were_VBD
examined_VBN
on_IN
mononuclear_JJ
leukocytes_NNS
by_IN
measuring_JJ
-LCB-_-LRB-
3H-RCB-dexamethasone_NN
binding_NN
and_CC
the_DT
effect_NN
of_IN
dexamethasone_NN
on_IN
-LCB-_-LRB-
3H-RCB-thymidine_NN
incorporation_NN
,_,
which_WDT
represents_VBZ
an_DT
index_NN
of_IN
DNA_NN
synthesis_NN
._.

RESULTS_NNS
:_:
The_DT
number_NN
of_IN
glucocorticoid_NN
receptors_NNS
on_IN
mononuclear_JJ
leukocytes_NNS
-LRB-_-LRB-
MNL_NN
-RRB-_-RRB-
was_VBD
comparable_JJ
in_IN
patients_NNS
with_IN
anorexia_NN
nervosa_NN
,_,
patients_NNS
with_IN
active_JJ
Cushing_NN
's_POS
disease_NN
,_,
and_CC
normal_JJ
subjects_NNS
-LRB-_-LRB-
binding_NN
capacity_NN
3.3_CD
+_CC
\/_CD
-_:
0.23_CD
vs._CC
3.7_CD
+_CC
\/_CD
-_:
0.30_CD
and_CC
3.5_CD
+_CC
\/_JJ
-_:
0.20_CD
fmol\/10_NN
6_CD
cells_NNS
-RRB-_-RRB-
._.

Conversely_RB
,_,
glucocorticoid_NN
receptor_NN
affinity_NN
was_VBD
significantly_RB
decreased_VBN
in_IN
anorexia_NN
nervosa_NN
as_RB
well_RB
as_IN
in_IN
Cushing_NN
's_POS
patients_NNS
compared_VBN
to_TO
control_JJ
subjects_NNS
-LRB-_-LRB-
dissociation_NN
constant_NN
4.0_CD
+_CC
\/_CD
-_:
0.31_CD
and_CC
4.1_CD
+_CC
\/_CD
-_:
0.34_CD
vs._CC
2.9_CD
+_CC
\/_NN
-_:
0.29_CD
nmol\/L_NN
,_,
p_NN
&lt;_JJR
.001_CD
-RRB-_-RRB-
and_CC
inversely_RB
correlated_VBN
with_IN
the_DT
levels_NNS
of_IN
urinary_JJ
free_JJ
cortisol_NN
in_IN
both_DT
groups_NNS
of_IN
patients_NNS
._.

Basal_JJ
-LCB-_-LRB-
3H-RCB-thymidine_NN
incorporation_NN
in_IN
MNL_NN
was_VBD
significantly_RB
reduced_VBN
in_IN
anorexia_NN
nervosa_NN
as_RB
well_RB
as_IN
in_IN
Cushing_NN
's_POS
patients_NNS
compared_VBN
to_TO
control_JJ
subjects_NNS
-LRB-_-LRB-
p_NN
&lt;_JJR
.001_CD
-RRB-_-RRB-
and_CC
was_VBD
diminished_VBN
by_IN
dexamethasone_NN
to_TO
an_DT
extent_NN
similar_JJ
to_TO
control_JJ
subjects_NNS
in_IN
patients_NNS
with_IN
anorexia_NN
nervosa_NN
,_,
but_CC
significantly_RB
-LRB-_-LRB-
p_NN
&lt;_JJR
.001_CD
-RRB-_-RRB-
less_JJR
in_IN
those_DT
with_IN
Cushing_NN
's_POS
disease_NN
._.

In_IN
patients_NNS
with_IN
anorexia_NN
nervosa_NN
,_,
the_DT
incorporation_NN
of_IN
-LCB-_-LRB-
3H-RCB-thymidine_NN
into_IN
the_DT
MNL_NNS
was_VBD
inversely_RB
correlated_VBN
with_IN
urinary_JJ
free_JJ
cortisol_NN
levels_NNS
._.

CONCLUSIONS_NNS
:_:
These_DT
data_NNS
indicate_VBP
that_IN
the_DT
lack_NN
of_IN
cushingoid_JJ
features_NNS
in_IN
patients_NNS
with_IN
anorexia_NN
nervosa_NN
is_VBZ
not_RB
ascribable_JJ
to_TO
a_DT
reduced_VBN
sensitivity_NN
to_TO
glucocorticoids_NNS
but_CC
is_VBZ
more_RBR
likely_RB
due_JJ
to_TO
the_DT
paucity_NN
of_IN
metabolic_JJ
substrates_NNS
._.

